Sanofi Pasteur said it’s discontinuing the manufacture of TheraCys, an important bladder cancer drug, and shortages are expected, while the US Food and Drug Administration (FDA) on Friday released ...
rBCG offers an alternative to TICE® BCG amid U.S. shortages, impacting bladder cancer treatment availability. FDA's Expanded Access Program allows investigational rBCG use when no satisfactory ...
Bladder cancer is cancer that forms in the cells of the bladder. People often receive a diagnosis in its early stages when healthcare professionals can treat it successfully. Share on Pinterest Xavier ...
Therapeutic progress has accelerated, with multiple recent approvals improving outcomes across early-stage, muscle-invasive, and metastatic urothelial carcinoma. FGFR3 and HER2 protein expression by ...
What Is BCG Treatment for Bladder Cancer? Bacillus Calmette-Guérin (BCG) is the main immunotherapy used to treat early-stage bladder cancer. Immunotherapy uses your immune system to fight cancer. BCG ...
TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...
Historic surgery, the result of years of research at Keck Medicine of USC and UCLA Health, opens the door for improved treatment of non-functioning bladders “This surgery is a historic moment in ...
Hosted on MSN
Why your bladder deserves better habits
Many of us have been told to ‘go just in case’ before leaving the house, but experts say this can actually train your bladder to signal too early. Healthy urination patterns depend on hydration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results